iShares $ Corp Bond ETF USD Dist (LQDA)

12.32 -0.05 (-0.40%) As of 10:25AM EDT. Market open.

iShares $ Corp Bond ETF USD Dist

419 Davis Drive
Suite 100
Morrisville, NC 27560
United States
919 328 4400
https://www.liquidia.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 145

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Roger A. Jeffs Ph.D.	CEO & Director	532.23k	N/A	1962
Mr. Michael Kaseta	COO & CFO	627.85k	N/A	1977
Mr. Russell Schundler	General Counsel & Corporate Secretary	541.92k	N/A	1975
Mr. William R. Kenan Jr.	Co-Founder	N/A	N/A	N/A
Dr. Ginger Denison	Co-Founder	N/A	N/A	N/A
Jennifer Almond	Director of Investor Relations & Corporate Communications	N/A	N/A	N/A
Ms. Sarah Krepp SPHR	Vice President of People & Culture	N/A	N/A	N/A
Mr. Jason Adair	Chief Business Officer	N/A	N/A	1974
Dr. Tushar Shah M.D.	Senior Vice President of Product Development	792.36k	N/A	1961
Mr. Scott Moomaw	Chief Commercial Officer	N/A	N/A	1971

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Corporate governance

iShares $ Corp Bond ETF USD Dist’s ISS governance QualityScore as of 1 April 2024 is 10. The pillar scores are Audit: 9; Board: 10; Shareholder rights: 6; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.